Trial intelligence / Profile preview

Phase IV open-label trial of paritaprevir/ritonavir, ombitasvir, dasabuvir with or without ribavirin in chronic hepatitis C genotype 1 with recent injection drug use or opioid substitution therapy

2015-003562-90Phase 4Completed

Sponsor

The Kirby Institute

Start

Jul 2016

Modality

Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1